Zhittya Genesis Medicine’s Investigational Therapy for Parkinson’s to Enter Phase 1 Trials in Mexico
Mexico’s Federal Commission for the Protection against Sanitary Risk (COFEPRIS) has granted approval for the first in-human clinical trial…
Articles by Marisa Wexler, MS
Light-activated Protein Used to Improve Mitochondrial Function, Reduce Parkinson’s Symptoms in Fly Study
Using a light-activated protein to improve the function of mitochondria — cells’ powerhouses— could be a therapeutic strategy for…
APOE Gene Variants Alter Alpha-synuclein Dynamics, Could Affect Dementia Occurrence in Parkinson’s, Study Suggests
Genetic variations in the gene apolipoprotein E (APOE) alter the dynamics of alpha-synuclein protein buildup in the brains…
Structural Differences Seen in Toxic Proteins Marking Parkinson’s, Multiple System Atrophy
Assessing the shape of alpha-synuclein aggregates in the brain helps to distinguish between Parkinson’s disease (PD) and another progressive neurodegenerative…
Oral Treatment in Phase 2 Trial, NYX-458, Seen to Aid Cognition in Primate Model Study
Aptinyx‘s investigational oral compound NYX-458 was able to ease cognitive difficulties in a non-human primate model of Parkinson’s…
Imaging Analysis Software QyScore Receives FDA Clearance
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Qynapse‘s QyScore, a software that…
FDA Response Bolsters Affiris’ Plans for Potential Parkinson’s Vaccine Affitope
The U.S. Food and Drug Administration (FDA) has responded to Affiris‘ Â pre-investigational new drug (IND) submission regarding…
RNA-targeting Molecule May Open New Avenue For Treating Parkinson’s, Study Suggests
A new small molecule called synucleozid can prevent cells from producing the Parkinson’s-associated protein alpha-synuclein by inhibiting its translation…
Data in Online Fox Insight Surveys Similar to Traditional Efforts in Parkinson’s, Study Finds
People with Parkinson’s disease taking part in the Fox Insight study, where they self-report details about their illness, share similar…
Stimulating Blood Vessel Growth in Brain With FGF1 May Hold Promise as PD Treatment, Company Says
Stimulating the growth of blood vessels in the brain through the use of fibroblast growth factor 1 (FGF1) may…